GeneDx
WGS
Performance
About GeneDx
GeneDx is a leading clinical laboratory specializing in genome and exome sequencing to diagnose genetic disorders. The company serves patients and healthcare providers with comprehensive genomic testing across has a focus on rare diseases, newborns, and pediatric cases, offering rapid and precise diagnostic insights. Headquartered in the United States, GeneDx emphasizes actionable results, genetic counseling, and support as part of its diagnostic workflow.
Recent News
It’s Time to Take Genetic Testing Off the Pedestal
Do You Believe in GeneDx Holdings Corp.’s (WGS) Durable Competitive Moat?
InsideArbitrage Event Driven Monitor – June 9, 2026
Prosight Management Invests $43M in GeneDx to Accelerate Genomics Testing Growth
Alphabet Boosts Portfolio Value by $1.5 B, Adds CME Group as Top Holding
The $130 Billion Acquisition of Dominion Energy – The Special Situations Report Episode 68
Why We’re Still Finding Cancer Too Late
Recent Deals
No recent deals for this company.